Its main mechanism of action would be its ability to bind to serum calcium, preventing activation of the coagulation cascade and prolonging the time till blood clot formation
Novo Nordisk, maker of Ozempic and Wegovy, provided the below statement to Fox News Digital
7157 Asian [4.49%], 25 121 Black [15.76%], and 102 381 White [64.23%]), including 79 699 patients in the semaglutide or tirzepatide group and 79 699 patients in the comparison group
Several studies have shown that glutathione may help prevent it
In these pathway categories, the most highly affected pathways were valine, leucine, and isoleucine biosynthesis (Additional file 6: Figure S6)
Both medications belong to the class of GLP-1 receptor agonists, but Tirzepatide introduces a dual-action approach that has shown promising results in various studies